Citations

Clear

1526 citation(s) found for "Sun, Yu".

Growth Differentiation Factor-15, Treatment with Liraglutide, and Clinical Outcomes Among Patients with Heart Failure
Sharma, Abhinav , Greene, Stephen J. , Fudim, Marat , Ambrosy, Andrew P. , Sun, Jie‐Lena , McNulty, Steven E., Mentz, Robert J. , Felker, G. Michael , Mentz, Robert J , Vaduganathan, Muthiah , Hernandez, Adrian F. , Borlaug, Barry A. , Velazquez, Eric J. , DeVore, Adam D. , Alhanti, Brooke , Margulies, Kenneth B.

Mayo Clinic

ESC Heart Failure | June 1, 2021 | Volume: 8 | Issue: 4 | Pages: 2608-2616

10.1002/ehf2.13348 | PMID 34061470 Get It

Abstract Aims Associations between growth differentiation factor-15 (GDF-15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HFrEF) are unknown. We utilized data from the ‘Functional Impact of GLP-1 for Heart Failure Treatment’ (FIGHT) study to address these knowledge gaps. Methods and results FIGHT was a randomized clinical trial testing the effect of liraglutide (vs. placebo) among 300 participants with HFrEF and a recent HHF. Multivariable regression models evaluated associations between baseline GDF-15 and change in GDF-15 (per 1000 pg/mL increase from baseline to 30 days) with clinical outcomes (at 180 days) and declines in exercise capacity (6 min walk distance ≥ 45 m). At baseline (n = 249), median GDF-15 value was 3221 pg/mL (interquartile range 1938–5511 pg/mL). Participants in the highest tertile of baseline GDF-15 were more likely to be male and have more co-morbidities. After adjustment, an increase in GDF-15 over 30 days was associated with higher risk of death or HHF [hazard ratio 1.35, 95% confidence interval (CI) 1.11–1.64]. In addition, higher baseline GDF-15 (per 1000 pg/mL until 6000 pg/mL) and an increase in GDF-15 over 30 days were associated with declining 6 min walk distance (odds ratio 1.26, 95% CI 1.02–1.55 and odds ratio 1.37, 95% CI 1.12–1.69, respectively). GDF-15 levels remained stable among participants randomized to liraglutide. Conclusions An increase in GDF-15 over 30 days among patients in HFrEF was independently associated with an increased risk of cardiovascular events and declining exercise capacity. These results support the value of longitudinal GDF-15 trajectory in informing risk of heart failure disease progression.
APOE Allele Testing and Alzheimer Disease—Reply
Choudhury, Parichita , Choudhury, Parichita , Ramanan, Vijay K. , Boeve, Bradley F.

Mayo Clinic

JAMA | June 1, 2021 | Volume: 325 | Issue: 21 | Pages: 2211

10.1001/jama.2021.4925 | PMID 34061147 Get It

Does Proton Pump Inhibitor Use Lead to a Higher Risk of Coronavirus Disease 2019 Infection and Progression to Severe Disease? a Meta-analysis
Yan, Cunye, Chen, Yue , Sun, Chenyu , Bhan, Chandur , Guo, Zhichun , Yang, Hongru , Zuo, Yijing , Yan, Yue , Hu, Lei , Sun, Yiceng , Li, Yao , Zhou, Qin , Sun, Chenyu , Ahmed, Mubashir Ayaz

Mayo Clinic

Japanese Journal of Infectious Diseases | May 30, 2021 | Volume: 75 | Issue: 1 | Pages: 10-15

10.7883/yoken.jjid.2021.074 | PMID 34053958 Get It

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Park, JooYong , Choi, Ji‐Yeob , Chung, Seokang , Song, Nan , Park, Sue K. , Han, Wonshik , Noh, Dong‐Young , Ahn, Sei-Hyun, Lee, Jong Won, Kim, Mi Kyung , Jee, Sun Ha , Wen, Wanqing , Bolla, Manjeet K. , Wang, Qin , Michailidou, Kyriaki , Shah, Mitul , Conroy, Don, Harrington, Patricia, Mayes, Rebecca , Hall, Per , Patel, Alpa V. , Couch, Fergus J. , Sawyer, Elinor J. , Roylance, Rebecca , Bojesen, Stig E. , Flyger, Henrik, Lambrechts, Diether , Baten, Adinda , Matsuo, Keitaro , Ito, Hidemi , Guénel, Pascal , Keeman, Renske , Schmidt, Marjanka K. , Wu, Anna H. , Tseng, Chiu-Chen, Cox, Angela , Investigators, kConFab, Andrulis, Irene L. , Hopper, John L., Wu, Pei‐Ei , Shen, Chen‐Yang , Fasching, Peter A. , Ekici, Arif B. , Muir, Kenneth, Brenner, Hermann , Arndt, Volker , Jones, Michael E. , Swerdlow, Anthony J, Hoppe, Reiner , Ko, Yon-Dschun, Hartman, Mikael , Li, Jingmei , Mannermaa, Arto, Hartikainen, Jaana M. , Benítez, Javier, Haiman, Christopher A. , Dörk, Thilo , Bogdanova, Natalia , Teo, Soo‐Hwang , Taib, Nur Aishah Mohd , Fletcher, Olivia, Johnson, Nichola , Grip, Mervi, Winqvist, Robert , Nevanlinna, Heli , Lindblom, Annika , Wendt, Camilla, Kristensen, Vessela N. , Collaborators, NBCS, Tollenaar, Rob A.�E.�M. , Heemskerk‐Gerritsen, Bernadette A. M. , Bonanni, Bernardo , Hamann, Ute, Manoochehri, Mehdi, Martinez, Maria Elena, Easton, Douglas F., Yoo, Keun-Young, Lambrechts, Diether , Song, Nan , Park, Sue K , Kim, Mi Kyung , Dennis, Joe , Michailidou, Kyriaki , Hall, Per N , Matsuo, Keitaro , Ito, Hidemi , Keeman, Renske , Schmidt, Marjanka K , Fasching, Peter A , Brenner, Hermann , Arndt, Volker , Hartikainen, Jaana M , Dörk, Thilo , Bogdanova, Natalia V , Johnson, Nichola , Nevanlinna, H , Heemskerk-Gerritsen, Bernadette A M , Bonanni, Bernardo , Lambrechts, Diether , Teo, Soo H , Jones, Michael E , Lambrechts, Diether , Cox, Angela , Guénel, Pascal , Hartman, Mikael , Li, Jingmei , Ekici, Arif B , Bojesen, Stig E , Lindblom, Annika , Mohd Taib, Nur Aishah , Sawyer, Elinor J , Choi, Jaesung , Czene, Kamila , Teras, Lauren R. , Couch, Fergus J. , Olson, Janet E. , Truong, Thérèse , Cross, Simon S. , Investigators, kConFab, Southey, Melissa C. , Lophatananon, Artitaya , Ko, Yon‐Dschun, Mannermaa, Arto , González‐Neira, Anna , Fletcher, Olivia , Blomqvist, Carl , Wendt, Camilla, Collaborators, NBCS, Radice, Paolo , Manoochehri, Mehdi, Lacey, James V. , Dunning, Alison M. , Pharoah, Paul D.P. , Kang, Daehee

Mayo Clinic

Cancers | May 14, 2021 | Volume: 13 | Issue: 10 | Pages: 2370

10.3390/cancers13102370 | PMID 34069208 Get It

In this study we aim to examine gene–environment interactions (GxEs) between genes involved with estrogen metabolism and environmental factors related to estrogen exposure. GxE analyses were conducted with 1970 Korean breast cancer cases and 2052 controls in the case-control study, the Seoul Breast Cancer Study (SEBCS). A total of 11,555 SNPs from the 137 candidate genes were included in the GxE analyses with eight established environmental factors. A replication test was conducted by using an independent population from the Breast Cancer Association Consortium (BCAC), with 62,485 Europeans and 9047 Asians. The GxE tests were performed by using two-step methods in GxEScan software. Two interactions were found in the SEBCS. The first interaction was shown between rs13035764 of NCOA1 and age at menarche in the GE|2df model (p-2df = 1.2 × 10−3). The age at menarche before 14 years old was associated with the high risk of breast cancer, and the risk was higher when subjects had homozygous minor allele G. The second GxE was shown between rs851998 near ESR1 and height in the GE|2df model (p-2df = 1.1 × 10−4). Height taller than 160 cm was associated with a high risk of breast cancer, and the risk increased when the minor allele was added. The findings were not replicated in the BCAC. These results would suggest specificity in Koreans for breast cancer risk.
International consensus to standardise histopathological scoring for small bowel strictures in Crohn’s disease
Gordon, Ilyssa O. , Bokemeyer, Arne , Rosty, Christophe , Robert, Marie E. , Mao, Ren, Borralho, Paula , Pai, Reetesh K. , Odze, Robert D. , Feakins, Roger , Parker, Claire E. , Guizzetti, Leonardo , Nguyen, Tran M , Shackelton, Lisa M. , Sandborn, William J. , Baker, Mark E. , Bruining, David H. , Feagan, Brian G. , Pai, Rish K. , Rieder, Florian , Bettenworth, Dominik , Bokemeyer, Arne , Rosty, Christophe , Mao, Ren , Pai, Reetesh K , Bruining, David, Feagan, B G , Pai, R K , Rieder, Florian , Guizzetti, L , Gordon, Ilyssa O , Srivastava, Amitabh , Hertogh, Gert D. , Valasek, Mark A. , Li, Jiannan , Harpaz, Noam , Jairath, Vipul , Fletcher, Joel G.

Mayo Clinic

Gut | May 5, 2021 | Volume: 71 | Issue: 3 | Pages: 479-486

10.1136/gutjnl-2021-324374 | PMID 33952604 Get It

Objective Effective medical therapy and validated trial outcomes are lacking for small bowel Crohn’s disease (CD) strictures. Histopathology of surgically resected specimens is the gold standard for correlation with imaging techniques. However, no validated histopathological scoring systems are currently available for small bowel stricturing disease. We convened an expert panel to evaluate the appropriateness of histopathology scoring systems and items generated based on panel opinion. Design Modified RAND/University of California Los Angeles methodology was used to determine the appropriateness of 313 candidate items related to assessment of CD small bowel strictures. Results In this exercise, diagnosis of naïve and anastomotic strictures required increased bowel wall thickness, decreased luminal diameter or internal circumference, and fibrosis of the submucosa. Specific definitions for stricture features and technical sampling parameters were also identified. Histopathologically, a stricture was defined as increased thickness of all layers of the bowel wall, fibrosis of the submucosa and bowel wall, and muscularisation of the submucosa. Active mucosal inflammatory disease was defined as neutrophilic inflammation in the lamina propria and any crypt or intact surface epithelium, erosion, ulcer and fistula. Chronic mucosal inflammatory disease was defined as crypt architectural distortion and loss, pyloric gland metaplasia, Paneth cell hyperplasia, basal lymphoplasmacytosis, plasmacytosis and fibrosis, or prominent lymphoid aggregates at the mucosa/submucosa interface. None of the scoring systems used to assess CD strictures were considered appropriate for clinical trials. Conclusion Standardised assessment of gross pathology and histopathology of CD small bowel strictures will improve clinical trial efficiency and aid drug development.
An Implementation and Longitudinal Evaluation Framework of Remote Quality Improvement Initiatives
Li, H., Sun, Yiming , Dong, Y., Cui, W., Leppin, Aaron L. , Sun, Y., Dong, Y., Tekin, A., Kashyap, R., Cui, W., Gajic, Ognjen , Niven, Alexander S.

Mayo Clinic

TP55. TP055 MECHANICAL VENTILATION, ICU MANAGEMENT, AND CV | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2851-A2851

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2851 Get It

A Virtual Simulation Platform for Structured Early Recognition and Treatment of Acute Illness
Li, H., Sun, Yulong , Bogojevic, M., Finch, Alex, Gajić, Ognjen, Tekin, Aysun , Flurin, Laure , Gajic, Ognjen , Niven, Alexander S. , Dong, Yue

Mayo Clinic

TP55. TP055 MECHANICAL VENTILATION, ICU MANAGEMENT, AND CV | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2821-A2821

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2821 Get It

Implementation of a Novel Multimodal Learning Needs Assessment for an International Interprofessional Critical Care Quality Improvement Initiative
Li, H., Sun, Yulong , Cui, Wen‐Chao , Gajić, Ognjen, Tekin, Aysun , Barwise, Amelia , Qiao, Lujun , Dong, Yue , Gajic, Ognjen , Niven, Alexander S.

Mayo Clinic

TP56. TP056 NONPULMONARY CRITICAL CARE AND LUNG INFECTION | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2874-A2874

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2874 Get It

A Case of Functional Adrenal Insufficiency Secondary to COVID-19 Infection
Djondo, D., Ahmed, Mubashir Ayaz , Sun, Chenyu , Mohan, A.

Mayo Clinic

TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A4086-A4086

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4086 Get It

The 'X' Factor: Exploring COVID-19 Viral Shedding in X-Linked Agammaglobulinemia. Can PCR Cell Cycle Threshold Play a Role?
Djondo, D., Ahmed, Mubashir Ayaz , Verghese, Dhiran , Sun, Chenyu , Mohan, A.

Mayo Clinic

TP31. TP031 INTERESTING CASES ASSOCIATED WITH SARS-COV-2 INFECTION | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2007-A2007

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2007 Get It